✦ LIBER ✦

High-Dose Probiotics for the Treatment of Active Pouchitis

✍ Scribed by Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosi Tambasco; Carlo Calabrese; Patrizia Brigidi; Beatrice Vitali; Giulia Straforini; Massimo Campieri

Book ID: 106322945
Publisher: Springer
Year: 2007
Tongue: English
Weight: 293 KB
Volume: 50
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-007-9068-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-Dose Probiotics for the Treatment o

High-Dose Probiotics for the Treatment of Active Pouchitis

✍ Paolo Gionchetti; Fernando Rizzello; Claudia Morselli; Gilberto Poggioli; Rosi T 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

Leukocytapheresis for the treatment of a

Leukocytapheresis for the treatment of active pouchitis: a pilot study

✍ Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yas 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 430 KB

High dose probiotic and prebiotic cother

High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease

✍ Shunji Fujimori; Atsushi Tatsuguchi; Katya Gudis; Teruyuki Kishida; Keigo Mitsui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Rifaximin for the treatment of active po

Rifaximin for the treatment of active pouchitis: A randomized, double-blind, placebo-controlled pilot study

✍ Kim L. Isaacs; Robert S. Sandler; Maria Abreu; Michael F. Picco; Stephen B. Hana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of rifaximin in patients with active pouchitis. eighteen patients with

The evolving background for high-dose tr

The evolving background for high-dose treatment for myeloma

✍ Sirohi, B; Powles, R; Harousseau, J L; Anderson, K C 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Activity of high-dose cyclophosphamide i

Activity of high-dose cyclophosphamide in the treatment of childhood malignant gliomas

✍ McCowage, Geoffrey B.; Friedman, Henry S.; Moghrabi, Albert; Kerby, Tracy; Ferre 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 3 views

Seventeen patients less than or equal to 20 years of age with newly diagnosed (n = 10) or recurrent (n = 7) malignant gliomas (anaplastic astrocytoma and glioblastoma multiforme) were treated with cyclophosphamide in association with hematopoietic cytokines (GM-CSF or G-CSF). Cyclophosphamide was gi